IN2014DN05011A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN05011A IN2014DN05011A IN5011DEN2014A IN2014DN05011A IN 2014DN05011 A IN2014DN05011 A IN 2014DN05011A IN 5011DEN2014 A IN5011DEN2014 A IN 5011DEN2014A IN 2014DN05011 A IN2014DN05011 A IN 2014DN05011A
- Authority
- IN
- India
- Prior art keywords
- nmo
- diagnosing
- materials
- methods
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
Abstract
The present invention provides for methods and materials for diagnosing and treating neuromyelitis optica (NMO) and related disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/723,180 US7101679B2 (en) | 2003-11-25 | 2003-11-25 | Marker for neuromyelitis optica |
PCT/US2004/039710 WO2005051178A2 (en) | 2003-11-25 | 2004-11-24 | Marker for neuromyelitis optica |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN05011A true IN2014DN05011A (en) | 2015-07-10 |
Family
ID=34592190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN5011DEN2014 IN2014DN05011A (en) | 2003-11-25 | 2004-11-24 |
Country Status (9)
Country | Link |
---|---|
US (5) | US7101679B2 (en) |
EP (1) | EP1700120B1 (en) |
JP (1) | JP4538464B2 (en) |
CN (1) | CN1910456B (en) |
AT (1) | ATE424560T1 (en) |
DE (1) | DE602004019812D1 (en) |
ES (1) | ES2320006T3 (en) |
IN (1) | IN2014DN05011A (en) |
WO (1) | WO2005051178A2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101679B2 (en) | 2003-11-25 | 2006-09-05 | Mayo Foundation For Medical Education And Research | Marker for neuromyelitis optica |
US20070093673A1 (en) * | 2005-10-24 | 2007-04-26 | Andre Vachereau | Boron-containing compounds, uses and preparation thereof |
JP4273235B2 (en) * | 2006-06-01 | 2009-06-03 | 国立大学法人 新潟大学 | Aquaporin 4 inhibitor |
WO2009039363A2 (en) * | 2007-09-20 | 2009-03-26 | Mayo Foundation For Medical Education And Research | Neuromyelitis optica autoantibodies as a marker for neoplasia |
JP5117336B2 (en) * | 2008-09-18 | 2013-01-16 | 国立大学法人 千葉大学 | Method for measuring test markers for multiple sclerosis or NMO |
US9891219B2 (en) * | 2008-10-10 | 2018-02-13 | Mayo Foundation For Medical Education And Research | Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive |
GR1007341B (en) | 2010-04-21 | 2011-07-05 | ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%), | Diagnostic assay |
WO2011142901A1 (en) | 2010-05-13 | 2011-11-17 | University Of Medicine And Dentistry Of New Jersey | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
DE102011011280A1 (en) | 2011-02-15 | 2012-08-16 | Euroimmun Medizinische Labordiagnostika Ag | Diagnostic kit and a method for examining a human patient sample for the presence of neuromyelitis optica-specific antibodies |
JP6152090B2 (en) * | 2011-04-21 | 2017-06-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate | Compositions and methods for treating optic neuritis |
US10132817B2 (en) | 2011-07-12 | 2018-11-20 | Rowan University | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
US20140371132A1 (en) * | 2011-10-21 | 2014-12-18 | The Board Of Regents Of The University Of Texas System | Codon signature for neuromyelitis optica |
EP2833140B1 (en) * | 2012-03-30 | 2018-05-09 | Konica Minolta, Inc. | Method for detecting biological material |
US20150139981A1 (en) * | 2012-05-21 | 2015-05-21 | The Regents Of The University Of California | Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis optica |
CN102898513B (en) * | 2012-10-31 | 2016-03-16 | 徐俊 | ELISpot optic neuromyelitis diagnostic kit and application thereof |
EP2979094B1 (en) | 2013-03-28 | 2018-08-29 | Protagen AG | Method for the diagnosis of neuromyelitis optica |
EP3145528A4 (en) * | 2014-05-19 | 2018-03-14 | The Johns Hopkins University | Highly soluble aquaporin-4 extracelluar loop c peptide immunization for treatment of neuromyelitis optica |
CN106661623A (en) * | 2014-06-30 | 2017-05-10 | 西门子医疗有限公司 | Diagnosis of neuromyelitis optica vs. multiple sclerosis using mirna biomarkers |
CN104698190A (en) * | 2015-03-16 | 2015-06-10 | 中国人民解放军总医院 | Biological diagnosis marker for central nervous system demyelinating diseases |
US10098935B2 (en) * | 2015-05-01 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Aquaporin tolerizing vaccines and methods of use thereof |
US10912926B2 (en) * | 2016-05-13 | 2021-02-09 | C. R. Bard, Inc. | Peripherally inserted central catheter systems, devices, and methods thereof for pediatrics |
CN106318974A (en) * | 2016-08-29 | 2017-01-11 | 南方医科大学南方医院 | Cell immobilization technology and AQP4 antibody detection kit prepared through same |
KR101977843B1 (en) | 2017-02-16 | 2019-05-13 | 국립암센터 | Biomarker for diagnosis of Neuromyelitis optica and Multiple sclerosis and Use thereof |
JP7067800B2 (en) * | 2017-04-12 | 2022-05-16 | 国立大学法人九州大学 | Neuropathic pain markers and their use |
KR102089042B1 (en) * | 2017-05-16 | 2020-03-13 | 서울대학교병원 | Improved method for detecting anti-aquaporin 4 antibody using complement inactivation |
CN108998450A (en) * | 2018-08-08 | 2018-12-14 | 昆明医科大学第附属医院 | Primer, cDNA, carrier, AQP4 monoclonal antibody and preparation method |
CN110618264A (en) * | 2019-09-10 | 2019-12-27 | 南方医科大学 | Method for detecting anti-AQP 4 antibody based on quantum dot polystyrene microspheres |
CN111272998A (en) * | 2020-01-09 | 2020-06-12 | 天津天海新域生物科技有限公司 | Method for simultaneously detecting central demyelinating autoantibodies AQP4, MOG and MBP |
CN115232795B (en) * | 2021-07-22 | 2023-09-19 | 北京和合医学诊断技术股份有限公司 | Cell strain for stably expressing AQP4-M23 protein, construction method and application thereof |
CN113358881B (en) * | 2021-08-10 | 2021-11-30 | 首都医科大学附属北京天坛医院 | Biomarker for NMOSD prediction or recurrence monitoring and application thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US37273A (en) * | 1863-01-06 | Improved canteen | ||
US4708713A (en) | 1984-11-16 | 1987-11-24 | Anisa Medical, Inc. | Method and system for removing immunosuppressive components from the blood of mammals |
US5258503A (en) | 1987-09-08 | 1993-11-02 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Autoantibody adsorbent and apparatus for removing autoantibodies using the same |
US5614192A (en) | 1989-07-19 | 1997-03-25 | Connective Therapeutics, Inc. | T cell receptor peptides as therapeutics for immune-related disease |
US5214136A (en) | 1990-02-20 | 1993-05-25 | Gilead Sciences, Inc. | Anthraquinone-derivatives oligonucleotides |
US5218105A (en) | 1990-07-27 | 1993-06-08 | Isis Pharmaceuticals | Polyamine conjugated oligonucleotides |
US5741671A (en) * | 1991-12-12 | 1998-04-21 | The Johns Hopkins University | Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1) |
US5324638A (en) | 1992-05-13 | 1994-06-28 | Sloan-Kettering Institute For Cancer Research | Brain transcription factor, nucleic acids encoding same and uses thereof |
DE4227695C1 (en) | 1992-08-21 | 1993-10-07 | Fresenius Ag | Centrifuge to separate blood into its components |
US5676644A (en) | 1995-06-07 | 1997-10-14 | Cobe Laboratories, Inc. | Extracorporeal blood processing methods and apparatus |
AU1059897A (en) | 1995-11-09 | 1997-05-29 | Trustees Of Boston University | Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector |
WO2000032387A1 (en) | 1998-11-25 | 2000-06-08 | Amarillo Biosciences, Inc. | Interferon-alpha mediated upregulation of aquaporin expression |
US20040014087A1 (en) | 1999-06-01 | 2004-01-22 | Incyte Corporation | Molecules for diagnostics and therapeutics |
US6409726B1 (en) * | 1999-11-08 | 2002-06-25 | Alan G. Ellman | Electrosurgical instrument for ear surgery |
US20030072737A1 (en) | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
US20040048253A1 (en) | 2001-02-21 | 2004-03-11 | Panzer Scott R. | Molecules for diagnostics and therapeutics |
US7251568B2 (en) | 2001-04-18 | 2007-07-31 | Wyeth | Methods and compositions for regulating bone and cartilage formation |
US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
US20040115629A1 (en) | 2002-01-09 | 2004-06-17 | Panzer Scott R | Molecules for diagnostics and therapeutics |
EP1376773B1 (en) * | 2002-06-22 | 2006-08-16 | Spinner GmbH | Coaxial Connector |
US7101679B2 (en) | 2003-11-25 | 2006-09-05 | Mayo Foundation For Medical Education And Research | Marker for neuromyelitis optica |
-
2003
- 2003-11-25 US US10/723,180 patent/US7101679B2/en not_active Expired - Lifetime
-
2004
- 2004-11-24 IN IN5011DEN2014 patent/IN2014DN05011A/en unknown
- 2004-11-24 AT AT04812269T patent/ATE424560T1/en not_active IP Right Cessation
- 2004-11-24 JP JP2006541455A patent/JP4538464B2/en active Active
- 2004-11-24 EP EP04812269A patent/EP1700120B1/en active Active
- 2004-11-24 WO PCT/US2004/039710 patent/WO2005051178A2/en active Application Filing
- 2004-11-24 DE DE602004019812T patent/DE602004019812D1/en active Active
- 2004-11-24 CN CN2004800408513A patent/CN1910456B/en active Active
- 2004-11-24 ES ES04812269T patent/ES2320006T3/en active Active
-
2006
- 2006-07-14 US US11/457,685 patent/US7947254B2/en active Active
-
2008
- 2008-04-18 US US12/105,755 patent/US8524508B2/en active Active
-
2012
- 2012-05-14 US US13/470,740 patent/US20120219969A1/en not_active Abandoned
-
2014
- 2014-06-02 US US14/293,105 patent/US20140314796A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20080145870A1 (en) | 2008-06-19 |
US20120219969A1 (en) | 2012-08-30 |
EP1700120A2 (en) | 2006-09-13 |
US7101679B2 (en) | 2006-09-05 |
EP1700120A4 (en) | 2007-11-14 |
US7947254B2 (en) | 2011-05-24 |
WO2005051178A2 (en) | 2005-06-09 |
WO2005051178A3 (en) | 2005-12-29 |
CN1910456A (en) | 2007-02-07 |
EP1700120B1 (en) | 2009-03-04 |
ES2320006T3 (en) | 2009-05-18 |
JP4538464B2 (en) | 2010-09-08 |
JP2007518068A (en) | 2007-07-05 |
US20090143710A1 (en) | 2009-06-04 |
ATE424560T1 (en) | 2009-03-15 |
DE602004019812D1 (en) | 2009-04-16 |
US8524508B2 (en) | 2013-09-03 |
US20050112116A1 (en) | 2005-05-26 |
US20140314796A1 (en) | 2014-10-23 |
CN1910456B (en) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN05011A (en) | ||
TNSN08255A1 (en) | Anti-mn antibodies and methods of using same | |
WO2002099054A3 (en) | Hccss as modifiers of the p53 pathway and methods of use | |
MY143215A (en) | Multifocal lenses for pre-presbyopic individuals | |
AU2003284238A1 (en) | Indentation hardness test system | |
WO2003066802A3 (en) | Gene expression analysis using nicking agents | |
WO2001075178A3 (en) | Methods for identifying peptide aptamers capable of altering a cell phenotype | |
IL200120A0 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes | |
WO2005009434A3 (en) | Compounds and methods for inducing apoptosis in cancer cells | |
WO2004053497A3 (en) | Method for predicting the response to her2-directed therapy | |
TW200609559A (en) | Contact lenses and methods for their design | |
TW200510398A (en) | Novel compounds | |
WO2004045376A3 (en) | Screening methods to identify treatments for autoimmune disease | |
WO2004045545A3 (en) | Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression | |
WO2004083241A3 (en) | Btc-interacting proteins and use thereof | |
AU2003223634A1 (en) | Peptide deformylase inhibitors | |
WO2004052919A3 (en) | Peptide deformylase inhibitors | |
AU2003293556A1 (en) | Methods of diagnosing and treating cancer | |
AU2003285485A1 (en) | 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION | |
AU2002258437A1 (en) | Peptide deformylase inhibitors | |
AU2003304490A1 (en) | Peptide deformylase inhibitors | |
AU2003294272A1 (en) | Methods for diagnosing the presence or stage of cancer | |
WO2003099783A3 (en) | Tropane compounds | |
AU2002322035A1 (en) | Peptide deformylase inhibitors | |
AU2003218695A1 (en) | Textile materials provided with calixarenes, method for the production thereof, and use thereof |